Thymosin Alpha-1 (TA1) is a synthetic 28-amino acid peptide used as an immune system modulator, often supplied in 10mg lyophilized vials for research. It enhances immune responses, aids in fighting chronic infections (Hepatitis, HIV), and supports cancer
Key Benefits
- Immune System Modulation: It acts as a biological response modifier, strengthening weakened immune systems (e.g., in elderly patients or during chronic infection) while calming overactive immune responses in autoimmune diseases.
- Enhanced T-Cell Function: Stimulates the maturation and function of T-cells (specifically CD4+ and CD8+), which are vital for destroying infected or cancer cells
- Antiviral & Antibacterial: Effective in managing chronic viral infections like Hepatitis B and C and reducing morbidity in sepsis.
- Reduced Inflammation: Helps lower chronic inflammation by balancing cytokine production.
- Adjunctive Cancer Support: Improves outcomes in cancer patients by boosting immune resilience during chemotherapy and radiation
IMPORTANT DISCLAIMERS:
